Protective Effects of Cinnamaldehyde against Mesenteric Ischemia-Reperfusion-Induced Lung and Liver Injuries in Rats

Oxid Med Cell Longev. 2020 Dec 9:2020:4196548. doi: 10.1155/2020/4196548. eCollection 2020.

Abstract

The aim of this study was to characterize and reveal the protective effects of cinnamaldehyde (CA) against mesenteric ischemia-reperfusion- (I/R-) induced lung and liver injuries and the related mechanisms. Sprague-Dawley (SPD) rats were pretreated for three days with 10 or 40 mg/kg/d, ig of CA, and then induced with mesenteric ischemia for 1 h and reperfusion for 2 h. The results indicated that pretreatment with 10 or 40 mg/kg of CA attenuated morphological damage in both lung and liver tissues of mesenteric I/R-injured rats. CA pretreatment significantly restored the levels of aspartate transaminase (AST) and alanine transaminase (ALT) in mesenteric I/R-injured liver tissues, indicating the improvement of hepatic function. CA also significantly attenuated the inflammation via reducing myeloperoxidase (MOP) activity and downregulating the expression of inflammation-related proteins, including interleukin-6 (IL-6), interleukin-1β (IL-1β), cyclooxygenase-2 (Cox-2), and tumor necrosis factor receptor type-2 (TNFR-2) in both lung and liver tissues of mesenteric I/R-injured rats. Pretreatment with CA significantly downregulated nuclear factor kappa B- (NF-κB-) related protein expressions (NF-κB p65, NF-κB p50, I kappa B alpha (IK-α), and inhibitor of nuclear factor kappa-B kinase subunit beta (IKKβ)) in both lung and liver tissues of mesenteric I/R-injured rats. CA also significantly downregulated the protein expression of p53 family members, including caspase-3, caspase-9, Bax, and p53, and restored Bcl-2 in both lung and liver tissues of mesenteric I/R-injured rats. CA pretreatment significantly reduced TUNEL-apoptotic cells and significantly inhibited p53 and NF-κB p65 nuclear translocation in both lung and liver tissues of mesenteric I/R-injured rats. CA neither induced pulmonary and hepatic histological alterations nor affected the parameters of inflammation and apoptosis in sham rats. We conclude that CA alleviated mesenteric I/R-induced pulmonary and hepatic injuries via attenuating apoptosis and inflammation through inhibition of NF-κB and p53 pathways in rats, suggesting the potential role of CA in remote organ ischemic injury protection.

MeSH terms

  • Acrolein / analogs & derivatives*
  • Acrolein / pharmacology
  • Acrolein / therapeutic use
  • Animals
  • Apoptosis / drug effects
  • Cytoprotection / drug effects
  • Disease Models, Animal
  • Inflammation / etiology
  • Inflammation / pathology
  • Inflammation / prevention & control
  • Kidney / blood supply
  • Kidney / drug effects
  • Kidney / pathology
  • Liver Diseases / etiology
  • Liver Diseases / pathology
  • Liver Diseases / prevention & control
  • Lung / blood supply
  • Lung / drug effects
  • Lung / pathology
  • Lung Injury / etiology
  • Lung Injury / pathology
  • Lung Injury / prevention & control
  • Male
  • Mesenteric Ischemia / complications
  • Mesenteric Ischemia / drug therapy*
  • Mesenteric Ischemia / pathology
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury / etiology
  • Reperfusion Injury / pathology
  • Reperfusion Injury / prevention & control*

Substances

  • Acrolein
  • cinnamaldehyde